{
  "template_name": "FormQAR-054 Slot-Based Template",
  "version": "1.0",
  "description": "Complete slot mapping guide for programmatic PSUR generation",
  
  "slot_syntax": {
    "format": "{{slot:slot_name}}",
    "appearance": "Blue italic text in Word document",
    "replacement_method": "Search and replace {{slot:slot_name}} with actual content"
  },
  
  "cover_page": {
    "manufacturer_company_name": {
      "type": "text",
      "label": "Company Name:",
      "required": true,
      "example": "CooperSurgical, Inc."
    },
    "manufacturer_address_line1": {
      "type": "text",
      "label": "Address (Company Name)",
      "required": true,
      "example": "CooperSurgical, Inc."
    },
    "manufacturer_address_line2": {
      "type": "text",
      "label": "Address (Street)",
      "required": true,
      "formatting": "Indented ~18 spaces",
      "example": "95 Corporate Drive, Trumbull, CT 06611"
    },
    "manufacturer_address_line3": {
      "type": "text",
      "label": "Address (Country)",
      "required": true,
      "formatting": "Indented ~18 spaces",
      "example": "United States of America"
    },
    "manufacturer_srn": {
      "type": "text",
      "label": "Manufacturer SRN:",
      "required": true,
      "example": "US-MF-000002607"
    },
    "ar_name": {
      "type": "text",
      "label": "Authorized Representative:",
      "required": false,
      "example": "CooperSurgical Distribution B.V."
    },
    "ar_address_line1": {
      "type": "text",
      "label": "AR Address Line 1:",
      "required": false,
      "formatting": "Heavily indented",
      "example": "Celsiusweg 35"
    },
    "ar_address_line2": {
      "type": "text",
      "label": "AR Address Line 2:",
      "required": false,
      "formatting": "Heavily indented",
      "example": "5928 PR Venlo"
    },
    "ar_address_line3": {
      "type": "text",
      "label": "AR Address Line 3:",
      "required": false,
      "formatting": "Heavily indented",
      "example": "The Netherlands"
    },
    "ar_srn": {
      "type": "text",
      "label": "AR SRN:",
      "required": false,
      "example": "NL-AR-0000000059"
    },
    "certificate_number": {
      "type": "text",
      "label": "Certificate Number:",
      "required": true,
      "example": "768179"
    },
    "certificate_date": {
      "type": "date",
      "label": "Date of Issue:",
      "required": true,
      "format": "YYYY or DD Month YYYY",
      "example": "2024"
    },
    "nb_name": {
      "type": "text",
      "label": "Notified Body Name:",
      "required": true,
      "example": "BSI Group The Netherlands B.V."
    },
    "nb_number": {
      "type": "text",
      "label": "Notified Body Number:",
      "required": true,
      "example": "2797"
    },
    "psur_available": {
      "type": "checkbox",
      "label": "PSUR available within 3 working days:",
      "options": ["Yes", "No"],
      "format": "☒ Yes ☐ No",
      "example": "☒ Yes ☐ No"
    },
    "data_collection_period": {
      "type": "date_range",
      "label": "Data Collection Period:",
      "required": true,
      "format": "DD Month YYYY to DD Month YYYY",
      "example": "01 January 2024 to 31 December 2025"
    },
    "psur_cadence": {
      "type": "text",
      "label": "PSUR Cadence:",
      "required": true,
      "example": "Every 2 Years"
    }
  },
  
  "section_a_executive_summary": {
    "previous_actions": {
      "type": "paragraph",
      "label": "Actions and status from Previous Report:",
      "required": true,
      "guidance": "State actions from previous PSUR or 'This is the first PSUR...'",
      "example": "This is the first PSUR for the Fischer Cone Biopsy Excisor device family..."
    },
    "status_completed": {
      "type": "checkbox",
      "label": "Completed",
      "format": "☐ or ☒"
    },
    "status_in_progress": {
      "type": "checkbox",
      "label": "In Progress",
      "format": "☐ or ☒"
    },
    "status_not_started": {
      "type": "checkbox",
      "label": "Not Started",
      "format": "☐ or ☒"
    },
    "status_details": {
      "type": "text",
      "label": "Details:",
      "example": "N/A"
    },
    "status_not_applicable": {
      "type": "checkbox",
      "label": "Not Applicable",
      "format": "☐ or ☒"
    },
    "nb_reviewed": {
      "type": "checkbox",
      "label": "Previous PSUR Reviewed by Notified Body:",
      "options": ["Yes", "No", "N/A"],
      "format": "☐ Yes ☐ No ☒ N/A",
      "example": "☐ Yes ☐ No ☒ N/A"
    },
    "nb_actions_taken": {
      "type": "text",
      "label": "Notified Body Actions Taken:",
      "example": "Not applicable. This is the initial PSUR."
    },
    "nb_actions_status": {
      "type": "text",
      "label": "Status of NB Actions:",
      "example": "N/A"
    },
    "period_changed": {
      "type": "checkbox",
      "label": "Data Collection Period Changed:",
      "options": ["Yes", "No"],
      "format": "☐ Yes ☒ No",
      "example": "☐ Yes ☒ No"
    },
    "change_justification": {
      "type": "text",
      "label": "Justification for Change:",
      "example": "N/A"
    },
    "comparability_impact": {
      "type": "text",
      "label": "Impact on Comparability:",
      "example": "N/A"
    },
    "benefit_risk_unchanged": {
      "type": "checkbox",
      "label": "has NOT been adversely impacted and remains UNCHANGED",
      "format": "☐ or ☒"
    },
    "benefit_risk_impacted": {
      "type": "checkbox",
      "label": "has been adversely impacted",
      "format": "☐ or ☒"
    },
    "benefit_risk_summary": {
      "type": "paragraph",
      "label": "Benefit-Risk Summary",
      "required": true,
      "guidance": "1-3 paragraphs: devices distributed, complaint rate %, serious incidents, findings, conclusion",
      "example": "The comprehensive analysis of post-market surveillance data collected during the reporting period from 01 January 2024 through 31 December 2025 supports the conclusion that the Fischer Cone Biopsy Excisor maintains a favorable benefit-risk profile. Throughout this period, approximately 6,183 devices were distributed globally, with a total of 15 complaints recorded. This represents an overall complaint rate of approximately 0.243 percent. No serious incidents were reported during the surveillance period..."
    }
  },
  
  "section_b_device_description": {
    "product_name": {
      "type": "text",
      "label": "Product Name:",
      "required": true,
      "example": "Fischer Cone Biopsy Excisor"
    },
    "implantable": {
      "type": "checkbox",
      "label": "Implantable Device:",
      "options": ["Yes", "No"],
      "format": "☐ Yes ☒ No",
      "example": "☐ Yes ☒ No"
    },
    "eu_class_iia": {
      "type": "checkbox",
      "label": "Class IIa",
      "format": "☐ or ☒"
    },
    "eu_class_iib": {
      "type": "checkbox",
      "label": "Class IIb",
      "format": "☐ or ☒"
    },
    "eu_class_iii": {
      "type": "checkbox",
      "label": "Class III",
      "format": "☐ or ☒"
    },
    "eu_td_number": {
      "type": "text",
      "label": "EU Technical Documentation Number:",
      "required": true,
      "example": "TD081"
    },
    "classification_rule": {
      "type": "text",
      "label": "Classification Rule:",
      "required": true,
      "example": "Rule 6 - Surgically invasive devices intended for transient use"
    },
    "us_class_i": {
      "type": "checkbox",
      "label": "US Class I",
      "format": "☐ or ☒"
    },
    "us_class_ii": {
      "type": "checkbox",
      "label": "US Class II",
      "format": "☐ or ☒"
    },
    "us_class_iii": {
      "type": "checkbox",
      "label": "US Class III",
      "format": "☐ or ☒"
    },
    "us_premarket_number": {
      "type": "text",
      "label": "US Pre-Market Submission Number:",
      "example": "K061651"
    },
    "eu_first_doc": {
      "type": "date",
      "label": "First Declaration of Conformity:",
      "example": "2006"
    },
    "eu_first_cert": {
      "type": "date",
      "label": "First EC/EU Certificate:",
      "example": "2012"
    },
    "eu_first_ce": {
      "type": "date",
      "label": "First CE-Marking:",
      "example": "2012"
    },
    "market_status": {
      "type": "text",
      "label": "Market status:",
      "required": true,
      "example": "On market (actively sold)"
    },
    "last_sold_date": {
      "type": "text",
      "label": "Last device sold date:",
      "example": "N/A - currently in active production"
    },
    "certificate_status": {
      "type": "text",
      "label": "Certificate status:",
      "example": "Valid"
    },
    "projected_end_pms": {
      "type": "text",
      "label": "Projected end of PMS period:",
      "example": "Cannot be determined - device actively marketed"
    },
    "psur_obligation": {
      "type": "text",
      "label": "Confirmation of ongoing PSUR obligation:",
      "required": true,
      "example": "PSUR obligation CONTINUES - device actively marketed"
    },
    "device_description": {
      "type": "paragraph",
      "label": "Device Description:",
      "required": true,
      "guidance": "1-3 paragraphs covering physical design, materials, sterility, packaging, technology",
      "example": "The Fischer Cone Biopsy Excisor is a single-use, sterile electrosurgical electrode designed to remove a conical shaped specimen from the cervix during LEEP procedures..."
    },
    "intended_purpose": {
      "type": "text",
      "label": "Intended Purpose/Use:",
      "required": true,
      "example": "The Fischer Cone Biopsy Excisor is intended to remove a conical shaped specimen from cervix during LEEP procedure."
    },
    "indications": {
      "type": "paragraph",
      "label": "Indications:",
      "required": true,
      "example": "Large Loop Excision of the Transformation Zone (LLETZ) in the diagnosis and treatment of Cervical Intraepithelial Neoplasias (CIN) and dysplasias..."
    },
    "contraindications": {
      "type": "paragraph",
      "label": "Contraindications:",
      "required": true,
      "example": "Absolute contraindications include hypovolemic shock, cardiac decompensation (Class IV), coagulopathy..."
    },
    "target_populations": {
      "type": "paragraph",
      "label": "Target populations:",
      "required": true,
      "example": "Women identified for treatment of Cervical Intraepithelial Neoplasias (CIN) where a cone biopsy specimen is removed..."
    },
    "mdr_devices_row{N}_col{N}": {
      "type": "table_cell",
      "table": "Basic UDI-DI Table",
      "columns": ["Basic UDI-DI", "Device Trade Name", "EMDN Code", "Changes from Previous PSUR"],
      "format": "{{slot:mdr_devices_row1_col0}} = Basic UDI-DI value",
      "guidance": "Dynamically create rows as needed"
    },
    "date_range": {
      "type": "date_range",
      "label": "Date Range:",
      "required": true,
      "format": "DD Month YYYY to DD Month YYYY",
      "example": "01 January 2024 to 31 December 2025"
    },
    "device_lifetime": {
      "type": "text",
      "label": "Device Lifetime:",
      "example": "Shelf life as indicated on product labeling (single use device)"
    },
    "projected_end": {
      "type": "text",
      "label": "Projected end of PMS period:",
      "example": "Cannot be determined while device remains actively marketed"
    },
    "rmf_number": {
      "type": "text",
      "label": "Risk Management File Number:",
      "required": true,
      "example": "RMF0023"
    },
    "associated_docs_row{N}_col{N}": {
      "type": "table_cell",
      "table": "Associated Documents Table",
      "columns": ["Document Type", "Document Number", "Document Title"],
      "format": "{{slot:associated_docs_row1_col0}} = Document Type",
      "example_rows": [
        ["PMS Plan", "BSR-QAR-002", "Post-Market Surveillance Procedure"],
        ["Clinical Evaluation Report", "CE081R", "Clinical Evaluation Report"],
        ["PMCF Plan", "CE081P", "Clinical Evaluation Plan"],
        ["Risk Management File", "RMF0023-RMR", "Risk Management Report"]
      ]
    },
    "catalog_numbers": {
      "type": "paragraph",
      "label": "Model/Catalog Numbers:",
      "required": true,
      "example": "900-150, 900-151, 900-152, 900-154, 900-155, 900-156, 900-157, 900-158"
    },
    "multiple_devices": {
      "type": "checkbox",
      "label": "Multiple Devices Included:",
      "options": ["Yes", "No"],
      "format": "☒ Yes ☐ No",
      "example": "☒ Yes ☐ No"
    },
    "grouping_information": {
      "type": "paragraph",
      "label": "Device Grouping Information:",
      "conditional": "If multiple devices = Yes",
      "guidance": "Justification, leading device, rationale, etc.",
      "example": "The Fischer Cone Biopsy Excisor family includes 8 catalog numbers representing variations in cone electrode size..."
    }
  },
  
  "section_c_sales": {
    "sales_criteria_*": {
      "type": "checkbox",
      "label": "Various sales criteria checkboxes",
      "guidance": "One checkbox for each criterion listed"
    },
    "market_history": {
      "type": "paragraph",
      "label": "Market History:",
      "required": true,
      "example": "The Fischer Cone Biopsy Excisor has been available since 2006, when it was first introduced to the market by Apple Medical Corporation..."
    },
    "sales_by_region_row{N}_col{N}": {
      "type": "table_cell",
      "table": "Table 1 - Sales by Region",
      "columns": ["Region", "Jan 2024 - Dec 2024", "Jan 2025 - Dec 2025", "% Global"],
      "regions": ["EEA+TR+XI", "Australia", "Brazil", "Canada", "China", "Japan", "UK", "United States", "Rest of World", "Worldwide"],
      "format": "{{slot:sales_by_region_row1_col1}} = 2024 sales for region",
      "guidance": "Populate with actual sales numbers"
    },
    "sales_analysis": {
      "type": "paragraph",
      "label": "Sales Data Analysis:",
      "required": true,
      "guidance": "Analyze trends, growth, regional distribution",
      "example": "The sales data shows total distribution of 6,183 devices during the surveillance period from January 2024 through December 2025..."
    },
    "single_use": {
      "type": "checkbox",
      "label": "Single Use per Patient:",
      "options": ["Yes", "No"],
      "format": "☒ Yes ☐ No"
    },
    "multiple_uses": {
      "type": "checkbox",
      "label": "Multiple Uses per Patient:",
      "options": ["Yes", "No"],
      "format": "☐ Yes ☒ No"
    },
    "population_size": {
      "type": "paragraph",
      "label": "Estimated Size of the Patient Population:",
      "required": true,
      "example": "Based on the total of approximately 6,183 devices distributed during the surveillance period and the single-use nature of the device..."
    },
    "population_characteristics": {
      "type": "paragraph",
      "label": "Characteristics of Patient Population:",
      "required": true,
      "example": "The patient population consists of women identified for treatment of Cervical Intraepithelial Neoplasias (CIN)..."
    }
  },
  
  "section_d_serious_incidents": {
    "section_d_content": {
      "type": "paragraph",
      "label": "Serious Incidents Summary:",
      "required": true,
      "guidance": "Include Tables 2, 3, 4 with IMDRF coding, rates, and investigation conclusions",
      "example": "Throughout the surveillance period from 01 January 2024 through 31 December 2025, no serious incidents were reported..."
    }
  },
  
  "section_e_customer_feedback": {
    "section_e_content": {
      "type": "paragraph",
      "label": "Customer Feedback Summary:",
      "required": true,
      "example": "Customer feedback was reviewed through the procedure for Post-Market Surveillance. During the surveillance period, no formal customer feedback distinct from product complaints was identified..."
    }
  },
  
  "section_f_complaints": {
    "section_f_content": {
      "type": "paragraph",
      "label": "Complaint Types and Rates:",
      "required": true,
      "guidance": "Include complaint rate calculation, Table 7 with rates by harm/problem",
      "example": "The complaint rate is calculated as the number of complaints received during the period divided by the estimated number of device uses. During the surveillance period, 15 complaints were received for 6,183 units distributed, yielding a complaint rate of approximately 0.243 percent."
    }
  },
  
  "section_g_trending": {
    "section_g_content": {
      "type": "paragraph",
      "label": "Trend Reporting:",
      "required": true,
      "guidance": "Monthly complaint rate graph, UCL analysis, trend reports",
      "example": "Statistical process control analysis was conducted to evaluate complaint rates throughout the surveillance period. No sustained upward trends, cyclical patterns, or systematic shifts were identified..."
    }
  },
  
  "section_h_fsca": {
    "section_h_content": {
      "type": "paragraph",
      "label": "Field Safety Corrective Actions:",
      "required": true,
      "example": "No Field Safety Corrective Actions were initiated during the data collection period from 01 January 2024 through 31 December 2025."
    }
  },
  
  "section_i_capa": {
    "section_i_content": {
      "type": "paragraph",
      "label": "Corrective and Preventive Actions:",
      "required": true,
      "example": "No CAPAs were initiated during the surveillance period related to device design, manufacturing process, or safety issues."
    }
  },
  
  "section_j_literature": {
    "section_j_content": {
      "type": "paragraph",
      "label": "Scientific Literature Review:",
      "required": true,
      "guidance": "Search methodology, findings, impact on benefit-risk",
      "example": "Systematic literature review was conducted covering the surveillance period. Literature searches confirmed that LEEP and cone biopsy procedures remain accepted standards of care..."
    }
  },
  
  "section_k_databases": {
    "section_k_content": {
      "type": "paragraph",
      "label": "External Databases Review:",
      "required": true,
      "guidance": "List databases searched, findings, Table 10",
      "example": "External regulatory databases were systematically monitored throughout the surveillance period including FDA MAUDE and other relevant databases..."
    }
  },
  
  "section_l_pmcf": {
    "section_l_content": {
      "type": "paragraph",
      "label": "Post Market Clinical Follow-Up:",
      "required": true,
      "guidance": "PMCF activities, findings, Table 11, or state N/A if not required",
      "example": "Post-market clinical follow-up activities were conducted throughout the surveillance period. No formal prospective PMCF studies were required..."
    }
  },
  
  "section_m_findings": {
    "section_m_content": {
      "type": "paragraph",
      "label": "Findings and Conclusions:",
      "required": true,
      "guidance": "Include sections a) through f): benefit-risk determination, benefits achieved, data limitations, new risks, actions, overall conclusion",
      "example": "a) Benefit-Risk Determination: Based on comprehensive analysis of all surveillance data collected during the period from 01 January 2024 through 31 December 2025, the benefit-risk profile of Fischer Cone Biopsy Excisor has NOT been adversely impacted and remains UNCHANGED..."
    }
  },
  
  "usage_guide": {
    "replacement_process": [
      "1. Load FormQAR-054_SLOT_TEMPLATE.docx",
      "2. Search for each {{slot:slot_name}} marker",
      "3. Replace with appropriate content from data sources",
      "4. Maintain original formatting (fonts, spacing, indentation)",
      "5. For checkboxes, use ☒ for checked, ☐ for unchecked",
      "6. For tables, add rows as needed using same format",
      "7. Remove empty conditional sections if not applicable",
      "8. Save completed PSUR"
    ],
    
    "validation_checklist": [
      "All required slots filled",
      "Checkboxes properly formatted (☒/☐)",
      "Tables have proper structure and data",
      "Dates in correct format",
      "Complaint rates shown as percentages (not per 1,000)",
      "No slot markers remaining in final document",
      "All formatting preserved",
      "Document flows naturally without gaps"
    ]
  }
}
